Mid-Size Pharmaceutical Market forecast to 2028 - covid-19 impact and global analysis" report added to the insight partners has covered and analyzed the potential of global Mid-Size Pharmaceutical Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global market. Additionally, the report also highlights market entry strategies for various companies across the globe

An exclusive Mid-Size Pharmaceutical Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.

According to our new research study on "Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Drug Development Type, Formulation, and Therapy Class," the mid-size pharmaceutical market is expected to grow from US$ 690,105.2 million in 2022 to US$ 1,000,584.3 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028. The report highlights the trends prevailing in the market and the factors driving the market growth. Increasing prevalence of chronic disorders and rising approvals and launches of products boost the market growth. However, cutthroat competition among market players hampers the growth of the mid-size pharmaceutical market.


The prominent/emerging players in the Mid-Size Pharmaceutical Market research include:

DAIICHI SANKYO COMPANY LIMITED
Eisai Co., Ltd.
Bausch Health Companies Inc.
Regeneron Pharmaceuticals, Inc
Sun Pharmaceutical Industries Ltd
Alexion Pharmaceuticals, Inc.
Mallinckrodt
Endo Pharmaceuticals Inc.
Les Laboratories Servier
UCB S.A.

The over-the-counter segment held a larger market share in 2022 and is expected to continue its dominance during the forecast period. Moreover, the same segment is expected to register a higher CAGR during the forecast period. Major factors driving the market growth for the over-the-counter segment are increasing budget allocation by pharmaceutical companies for the drugs marketing, higher disposable income, and the rising chronic diseases prevalence.

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876